TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
Journal article published in 2018 by
V. J. van den Berg 
,
D. O. Haskard,
A. Fedorowski,
A. Hartley,
I. Kardys,
M. Caga-Anan,
K. Martijn Akkerhuis,
R. M. Oemrawsingh,
R. J. van Geuns,
P. de Jaegere,
N. van Mieghem,
E. Regar,
J. M. R. Ligthart,
V. A. W. M. Umans,
P. W. Serruys
and other authors.
,
D. O. Haskard,
A. Fedorowski,
A. Hartley,
I. Kardys,
M. Caga-Anan,
K. Martijn Akkerhuis,
R. M. Oemrawsingh,
R. J. van Geuns,
P. de Jaegere,
N. van Mieghem,
E. Regar,
J. M. R. Ligthart,
V. A. W. M. Umans,
P. W. Serruys
and other authors.
